Beat COVID-19 - Observational Trial
JUPITER
A Virtual Observational Protocol to Gain Longitudinal Data in Participants to Help Understand COVID-19 Spread and Disease Progression
1 other identifier
observational
100,000
1 country
1
Brief Summary
JUPITER is an observational study protocol that aims to understand factors that can help prevent/mitigate the spread of COVID-19 and understand factors that help reduce disease progression in patients with COVID-19. We aim to accomplish this by obtaining self-reported historical and longitudinal data from study participants.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 6, 2020
CompletedStudy Start
First participant enrolled
April 6, 2020
CompletedFirst Posted
Study publicly available on registry
April 8, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2021
CompletedApril 9, 2020
April 1, 2020
8 months
April 6, 2020
April 8, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Health Outcomes
Patterns of data will be mined to understand risks for hospitalization and disease progression associated with COVID-19
1 year
Study Arms (2)
Healthy
Healthy adult individuals residing in the United States with no history of COVID-19
COVID-19 Confirmed
United States adults that have tested positive for SARS-CoV-2 virus which causes the human disease COVID-19 (IE novel coronavirus) or those that have been exposed to a confirmed case and are awaiting testing
Eligibility Criteria
English Speaking adults aged 18 years or older with an ability to self-report their medical history and provide regular updates via an electronic data capture web portal that can be accessed through internet connection. Observational period for this trial will be 30 days involving regular updates from participants for the duration. Participants will also be asked whether they wish to be informed about additional opportunities/future studies pertaining to COVID-19.
You may qualify if:
- Adults residing in the United States aged 18 years or older proficient in understanding and reading the English language who wish to participate in the fight against COVID-19 by providing self-reported health information.
- Ability to complete electronic informed consent process.
- Ability to use the internet and check email regularly.
- Consent to provide a HIPAA waiver of health information to share protected health information.
You may not qualify if:
- \. Inability to provide regular updates to their health status when contacted by the BEAT COVID study personnel via email or SMS.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Beat COVID LLClead
Study Sites (1)
Beat COIVD, LLC
Chicago, Illinois, 60452, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 6, 2020
First Posted
April 8, 2020
Study Start
April 6, 2020
Primary Completion
December 1, 2020
Study Completion
July 1, 2021
Last Updated
April 9, 2020
Record last verified: 2020-04